
|Articles|August 1, 2014
The European Parliament’s New Term: What Can We Expect?
Author(s)Guest Blogger
As Europe departs for its annual holiday-sacrosanct, even amid the continuing economic woes, the multiple crises in the Middle East, and the dark mysteries of Russia’s intentions in its former satellites-the question remains unresolved as to what to expect from the new European Parliament in the new term.
Advertisement
As Europe departs for its annual holiday-sacrosanct, even amid the continuing economic woes, the multiple crises in the Middle East, and the dark mysteries of Russia’s intentions in its former satellites-the question remains unresolved as to what to expect from the new European Parliament in the new term.
Philip Ward considers the options in this
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharma M&A Roundup: AstraZeneca Enters License Deal with Dizal Pharmaceutical, Chai Discovery Enters Collaboration with Novartis, Innovent Biologics Enters License Agreement with Spero Therapeutics
2
FDA Approves Leqembi Iqlik Subcutaneous Injection for Early Alzheimer’s Disease
3
Nuvation Bio’s Approach to Building a Compelling Narrative
4
Steer Bio Targets Lymphedema with Regenerative Cell Therapy Platform
5




